INO logo

INO Inovio Pharmaceuticals, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$1.76
+0.05 (+2.92%)

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identi…

Market Cap: $121.60Mwww.inovio.com

Price

No data yet.

Social Signal Score

37
5d
20
2 mentions
—
30d
42
12 mentions
—
60d
43
13 mentions
—
90d
44
18 mentions
—
news: 18

Analyst Ratings

17 analysts
Buyconsensus
Strong Buy 0Buy 11Hold 4Sell 2Strong Sell 0
Avg price target$4+127.3%
Low $3Median $4High $5
Current Consensus

Revenue

$298.9K-96.49%
$0.00$8.15M$16.30M$24.45M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-2.27
$-2.32–$-2.24
3 analysts
FY2026
$-0.90
$-0.91–$-0.89
2 analysts
FY2027
$-0.18
$-0.63–$0.29
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jacqueline E. Shea
Sector
Healthcare
Industry
Biotechnology
Employees
112
Beta
1.71
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-47.88
www.inovio.com